Implementation of a Biomarker into Drug Development: Example of Identifying the Right Imaging “Tool” for an Oncology Study

Barry T. Peterson1, Timothy J. McCarthy1, Philip S. Murphy2
1Global Clinical Technology, Pfizer Global Research and Development, Groton, Eastern Point Road, MS8260-2605, Connecticut, 06340, UK
2Global Clinical Technology, Pfizer Global Research and Development, Sandwich, Kent, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Finley Austin MJ, Babiss, L. Commentary: where and how could biomarkers be used in 2016. Am Assoc Pharm Sci J. 2006;8(1):E185–189.

Scaros O, Fisler R. Biomarker technology roundup: from discovery to clinical applications, a broad set of tools is required to translate from the lab to the clinic [review]. Biotechniques. April 2005;Suppl: 30–32.

Sablon E, Shapiro F, Zoulim F. Early detection of hepatitis B drug resistance: implications for patient management. Expert Rev Mol Diagn. 2003; 3(5):535–547.